Loading…
Anti L'Age, a dietary supplement manufacturer in Riverside, CA, was cited for serious Current Good Manufacturing Practice (CGMP) violations under 21 CFR Part 111 that rendered their products adulterated. The FDA inspection (September 17 – October 4, 2024) identified a critical failure to establish product specifications for identity, purity, strength, and composition, as well as contamination limits for finished batches including products like ESR Amino, Transfer Factor C, and others. The company had not responded to the FDA 483 inspectional observations as of the warning letter date, and the violations indicate the dietary supplements were prepared, packed, or held under conditions failing to meet CGMP requirements.